Research Article
The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung Cancer
Table 2
Probability of SCLC according to NSE and/or ProGRP serum levels.
| Criteria | Probability (SCLC/total lung cancer) |
| ProGRP > 50 pg/mL | 33.33% (81/243) | ProGRP > 75 pg/mL | 71.56% (73/102) | ProGRP > 100 pg/mL | 82.5% (66/80) | ProGRP > 125 pg/mL | 84.42% (65/77) | ProGRP > 150 pg/mL | 85.71% (60/70) | NSE > 25 ng/mL | 34.78% (48/138) | NSE > 30 ng/mL | 47.72% (42/88) | NSE > 35 ng/mL | 55.07% (38/69) | NSE > 40 ng/mL | 58.82% (30/51) | NSE > 45 ng/mL | 56.81% (25/44) | ProGRP > 100 pg/mL and NSE > 35 ng/mL | 92.11% (35/38) |
|
|